(177 days)
The MiniMed Quick-serter is indicated to use as an aid for inserting compatible devices. It is for use by a single patient. It is not for use by multiple patients.
The modified MiniMed Quick-serter (MMT-305) is a non-sterile, single patient, multi-use, hand held accessory product designed to be used as an insertion aid for compatible devices, including specific infusion sets. It is used to insert the introducer needle and cannula through the skin and into the subcutaneous tissue. The MiniMed Quick-serter is intended to be used by a patient or clinician as a means to insert an infusion set with minimum discomfort and technique dependency.
The MiniMed Quick-serter consists of a plastic barrel containing a stainless steel spring and a handle. The device user places and securely seats the infusion set into the MiniMed Quick-serter is loaded and locked by pulling the handle (compressing the spring) until it clicks/locks into place. The serter is placed in contact with the insertion site and fired to release the infusion set. This is done by depressing the green side buttons to release the spring, which drives the infusion set forward and the insertion needle and cannula are inserted into the user's subcutaneous tissue. The release button on the top of the device is then pressed to ease the release of the infusion set from the serter.
The provided text describes a 510(k) submission for the "MiniMed Quick-serter" (MMT-305) and compares it to a predicate device (MMT-395). This device is a syringe needle introducer, and the submission is focused on demonstrating substantial equivalence, not necessarily on detailing a study proving the device meets acceptance criteria in the way one would for a novel AI/software medical device.
Therefore, the information I can extract will be specific to the type of device and submission, which involves engineering and biocompatibility testing rather than clinical study protocols for diagnostic accuracy or comparative effectiveness with human readers.
Here's the breakdown based on the provided text:
1. A table of acceptance criteria and the reported device performance
The document lists performance testing that was conducted to verify the device's mechanical properties and functions. The "acceptance criteria" are implied by the statement "Results from performance testing indicate that the product meets the established performance requirements." Specific numerical acceptance criteria are not explicitly detailed for each test in this summary, but the reported device performance for some characteristics is given in the comparison table.
| Description | Acceptance Criteria (Implied) | Reported Device Performance (Modified MMT-305) |
|---|---|---|
| Classification | Class II | Class II |
| Product Code | KZH | KZH |
| Type of Use | Over the Counter | Over the Counter |
| Compatibility | MiniMed Quick-set Infusion Set, MiniMed Pro-set Infusion Set | MiniMed Quick-set Infusion Set, MiniMed Pro-set Infusion Set |
| Condition of use | Single patient, multi-use | Single patient, multi-use |
| Energy Source | Spring Driven | Spring Driven |
| Mode of action | Manual operation | Manual operation |
| Cocking Force | <5 lbf | Identical (to predicate, which is <5 lbf) |
| Trigger/release Force | <7 lbf | 0.67 lbf - 7lbf |
| Diameter | (Comparison to predicate) | 1.96 inches |
| Width of Pull Handle | (Comparison to predicate) | 1.59 inches |
| Set release button | Made distinct from pull handle | Set release button and pull handle are made distinct |
| Sterility | Non-sterile | Non-sterile |
| Validated Cleaning Method | Manual | Manual |
| Service Life | 3 years | 3 years |
| Biocompatibility | Acceptable for intended use | Acceptable for its intended use by Biological Evaluation (based on ISO 10993-1, -5, -10, -18) |
| Verification Testing | Meets "established performance requirements" | All listed tests completed and met internal standards/requirements. |
2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
The document does not specify the sample size for individual tests. The tests performed are engineering/mechanical verification, biocompatibility, and usability evaluations, not clinical studies with a "test set" in the context of patient data. The data provenance is internal to Medtronic MiniMed, and the tests are prospective, conducted on the device itself.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
This is not applicable to the type of device and testing described. "Ground truth" in this context would refer to established engineering standards, material science properties, and biocompatibility guidelines. The "experts" involved would be engineers, material scientists, and toxicologists conducting and evaluating the tests. No specific number or qualifications are mentioned for this section of the submission. A "Usability Evaluation" was performed, which would involve users, but details on "experts" for ground truth are not provided.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
This is not applicable. Adjudication methods are typically for clinical trials or diagnostic studies where there might be disagreement in expert opinions on patient data. The tests described are objective engineering and biocompatibility evaluations.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
This is not applicable. The device is a mechanical introducer, not AI software or a diagnostic tool.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
This is not applicable. The device is a mechanical device with a human user performing the insertion.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
The "ground truth" for the performance data in this submission aligns with:
- Established engineering standards: For tests like Cocking Force, Trigger Force, Life Cycle testing, Drop Test, etc., the ground truth is based on predefined engineering specifications and internal standards.
- International standards and regulatory guidance: For biocompatibility testing, the ground truth is based on standards such as ISO 10993-1, -5, -10, -18 and FDA #G95-1 guidance.
- Industry standards: For tasks like Ship Test (ASTM D4169) and Cleaning studies (AAMI TIR12, TIR30).
8. The sample size for the training set
This is not applicable. The device is a mechanical product, not a machine learning model that requires a training set.
9. How the ground truth for the training set was established
This is not applicable for the reasons stated above.
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized depiction of a human figure, represented by three overlapping profiles facing to the right. The profiles are black and are arranged in a way that suggests depth and connection. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the figure.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
September 22, 2016
Medtronic MiniMed Noreen Bajwa Sr. Regulatory Affairs Specialist 18000 Devonshire St. Northridge. California 91325
Re: K160860
Trade/Device Name: MiniMed Quick-serter Regulation Number: 21 CFR 880.6920 Regulation Name: Syringe Needle Introducer Regulatory Class: II Product Code: KZH Dated: August 24, 2016 Received: August 25, 2016
Dear Noreen Bajwa:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{1}------------------------------------------------
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely,
Image /page/1/Picture/8 description: The image shows a signature and the name "Tina Kiang". The signature is a stylized, looping design to the left of the name. Below the name, there is a letter "S".
Tina Kiang, Ph.D. Acting Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known)
Device Name
MiniMed Quick-serter
Indications for Use (Describe)
The MiniMed Quick-serter is indicated to use as an aid for inserting compatible devices. It is for use by a single patient. It is not for use by multiple patients.
Type of Use (Select one or both, as applicable)| | Prescription Use (Part 21 CFR 801 Subpart D)
|X | Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
Page 1 of 1
{3}------------------------------------------------
510(K) SUMMARY (21 CFR 807.92)
K160860
l. SUBMITTER [807.92(a)(1)]
Medtronic MiniMed, Inc. 18000 Devonshire Street Northridge, CA USA 91325
| Telephone: | (818) 576-5224 |
|---|---|
| Fax: | (818) 576-6273 |
| Contact Person: | Noreen Bajwa |
|---|---|
| Email: | noreen.bajwa@medtronic.com |
| Date Prepared: | September 21, 2016 |
II. DEVICE [807.92(a)(2)]
| Trade Name: | MiniMed Quick-serter |
|---|---|
| Common or Usual Name: | Syringe Needle Introducer |
| Regulation Name: | Introducer, Syringe Needle |
| Regulation Number: | 21 CFR §880.6920 |
| Product Code: | KZH |
| Regulatory Class: | II |
| Reviewing Product Branch: | General Hospital Devices Branch (GHDB) |
III. PREDICATE DEVICE [807.92(a)(3)]
MiniMed Quick-serter (MMT-395), infusion set insertion system (K992300)
Reference Devices
Purpose of Submission
The scope of this 510(k) submission includes modifications to the device design and additional compatibility to MiniMed Pro-set infusion set.
IV. DEVICE DESCRIPTION [807.92(a)(4)]
The modified MiniMed Quick-serter (MMT-305) is a non-sterile, single patient, multi-use, hand held accessory product designed to be used as an insertion aid for compatible devices, including specific
{4}------------------------------------------------
infusion sets. It is used to insert the introducer needle and cannula through the skin and into the subcutaneous tissue. The MiniMed Quick-serter is intended to be used by a patient or clinician as a means to insert an infusion set with minimum discomfort and technique dependency.
The MiniMed Quick-serter consists of a plastic barrel containing a stainless steel spring and a handle. The device user places and securely seats the infusion set into the MiniMed Quick-serter is loaded and locked by pulling the handle (compressing the spring) until it clicks/locks into place. The serter is placed in contact with the insertion site and fired to release the infusion set. This is done by depressing the green side buttons to release the spring, which drives the infusion set forward and the insertion needle and cannula are inserted into the user's subcutaneous tissue. The release button on the top of the device is then pressed to ease the release of the infusion set from the serter.
Devices compatible to MiniMed Quick-serter (MMT-305) include:
V. INDICATIONS FOR USE [807.92(a)(5)]
The MiniMed Quick-serter is indicated to use as an aid for inserting compatible devices. It is for use by a single patient. It is not for use by multiple patients.
The Indications for Use statement for the MiniMed Quick-serter is not identical to the predicate device. However, the differences do not affect the intended use of the device, nor does it affect the safety and effectiveness of the device relative to the predicate.
The predicate MiniMed Quick-serter (MMT-395) is indicated for use with MiniMed Quick-set family of infusion sets. The subject MiniMed Quick-serter (MMT-305) is indicated for use with compatible infusion sets including both MiniMed Quick-set and MiniMed Pro-set families of infusion sets. Both the predicate and subject MiniMed Quick-serter are indicated for single patient, multi-use and have the same intended use for automatic insertion of infusion sets.
VI. COMPARISON OF TECHNOLOGICAL CHARACTERISTICS [807.92(a)(6)]
The MiniMed Quick-serter has similar technological characteristics as the predicate device.
The energy source for both the predicate (MMT-395) and subject (MMT-305) MiniMed Quick-serter devices is spring driven. The predicate and subject devices operational principle and there are no different questions of safety and effectiveness as the subject MiniMed Quick-serter (MMT-305) falls within the same classification regulation, has the same intended use and retains the same fundamental scientific technology of the predicate MiniMed Quick-serter (MMT-395).
{5}------------------------------------------------
A comparison of the technological characteristics of the predicate (MMT-395) and subject (MMT-305) MiniMed Quick-serter are provided below:
| Description | (Predicate) MiniMed Quick-serter(MMT-395) | (Modified) MiniMed Quick-serter(MMT-305) |
|---|---|---|
| Classification | Class II | Identical |
| Product Code | KZH | Identical |
| Type of Use | Over the Counter | Identical |
| Compatibility | Maersk Medical A/S Contour infusionsets | MiniMed Quick-set Infusion SetMiniMed Pro-set Infusion Set |
| Condition of use | Single patient, multi-use | Identical |
| Energy Source | Spring Driven | Identical |
| Mode of action | Manual operation | Identical |
| Cocking Force | <5 lbf | Identical |
| Trigger/releaseForce | <7 lbf | 0.67 lbf -7lbf |
| Diameter | 1.89 inches | 1.96 inches |
| Width of PullHandle | 1.386 inches | 1.59 inches |
| Set release button | Set release button and pull handleare the same component | Set release button and pull handle aremade distinct |
| Sterility | Non-sterile | Identical |
| Validated CleaningMethod | Manual | Identical |
| Service Life | 3 years | Identical |
VII. PERFORMANCE DATA [807.92(b)]
The following performance data were provided in support of the substantial equivalence determinations:
Biocompatibility
The biocompatibility evaluation was conducted in accordance with the FDA #G95-1 "Use of International Standard ISO-10993, "Biological Evaluation of Medical Devices Part 1: Evaluation and Testing"" and international standard EN ISO 10993-1 "Biological Evaluation of Medical Devices Part 1: Evaluation and Testing Within A Risk Management Process" as recognized by FDA. The battery of testing included the following tests:
- . Chemical Characterization (EN ISO 10993-18)
- . Cytotoxicity (EN ISO 10993-5)
- Sensitization (EN ISO 10993-10)
- . Skin Irritation (EN ISO 10993-10)
The MiniMed Quick-serter has been evaluated for biocompatibility and is acceptable for its intended use by Biological Evaluation.
{6}------------------------------------------------
Verification Testing
The design of MiniMed Quick-serter (MMT-305) was verified to provide objective evidence that the device retains its mechanical properties and functions with MiniMed Quick-set and MiniMed Pro-set infusion sets.
Performance testing performed to support the design modifications included:
- Cocking Force
- Trigger Force
- Visual/Functional
- Life Cycle testing
- Drop Test ●
- Warehouse Environment Storage ●
- Home Environment Storage
- Operating Temperature
- Operating Humidity ●
- Mechanical Vibration
- Chemical Resistance
- Reliability
- Cleaning ●
- Robust Cleaning Life Test ●
- Usability Evaluation of Quick-set and Pro-set Insertion with Quick-serter
The aforementioned tests were completed to internal standards:
- . Ship Test - ASTM D4169 "Distribution Cycle 12, Assurance Level 1-Standard Practice for Performance Testing of Shipping Containers and Systems
- . Cleaning studies- AAMI TIR12 "Designing, testing and labeling reusable medical devices for reprocessing in healthcare facilities. A guide for medical device manufacturers" and AAMI TIR30 "A compendium of processes, materials, test methods, and acceptance criteria for cleaning reusable medical devices.
Results from performance testing indicate that the product meets the established performance requirements.
VIII. CONCLUSION
Based on the 510(k) Summary and information provided herein, we conclude the subject device, MiniMed Quick-serter (MMT-305), is substantially equivalent to the predicate MiniMed Quick-serter (MMT-395).
§ 880.6920 Syringe needle introducer.
(a)
Identification. A syringe needle introducer is a device that uses a spring-loaded mechanism to drive a hypodermic needle into a patient to a predetermined depth below the skin surface.(b)
Classification. Class II (performance standards).